Back to List

Pharmaceutical Affairs Act - Article 41

Pharmaceutical Affairs Act|第 41 條|Food and Drug Administration|Act|In Force

第 四 章|衛生福利部 / 食品藥物管理署|v107.01.31

Effective Date: 9999-12-31|Last Amended: 2026-03-04

Content

To enhance the standards of the pharmaceutical manufacturing industry and the quality of clinical trials, as well as to promote the research and development of pharmaceutical technology, the central competent health authority shall commission professional medical organizations annually to conduct educational training and cultivate talents for clinical trials. The research and development of emerging pharmaceutical technology may be rewarded by the central competent health authority and the central competent industry authority. The required qualifications, reviewing procedures, and other matters to be followed for the rewards under the preceding paragraph shall be established by the central competent health authority and the central competent industry authority.

Related Regulations - Pharmaceutical Affairs Act

  • Pharmaceutical Affairs Act - Article 27-2(第 27-2 條)
  • Pharmaceutical Affairs Act - Article 45(第 45 條)
  • Pharmaceutical Affairs Act - Article 39(第 39 條)
  • Pharmaceutical Affairs Act - Article 40(第 40 條)
  • Pharmaceutical Affairs Act - Article 40-1(第 40-1 條)
  • Pharmaceutical Affairs Act - Article 40-2(第 40-2 條)
  • Pharmaceutical Affairs Act - Article 40-3(第 40-3 條)